Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ewa Wachuła

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|January 2, 2021
Sleep disorders in oncological patientsDariusz Pysz-Waberski, Ewa Wachuła, Iwona Gisterek
Polish Archives of Internal Medicine|September 26, 2019
Emphysema affects the number and characteristics of solitary pulmonary nodules identified by chest low-dose computed tomography. A study on screenees with high-risk lung cancer recruited in Upper SilesiaEwa Wachuła, Sylwia Szabłowska-Siwik, Damian Czyżewski, et al.
Annals of Translational Medicine|May 20, 2016
Risk factors assessment and risk prediction models in lung cancer screening candidatesMariusz Adamek, Ewa Wachuła, Sylwia Szabłowska-Siwik, et al.
Endokrynologia Polska|June 28, 2014
An atypical course of pancreatic neuroendocrine tumour manifesting as cardiac metastasis - a clinical caseAgnieszka Boratyn-Nowicka, Jolanta Blicharz-Dorniak, Ewa Wachuła, et al.
Future Oncology (London, England)|May 10, 2016
Long-term efficacy of (90)Y-DOTATATE in patients with nonresectable pancreatic and small bowel neuroendocrine neoplasmsWojciech Rogowski, Ewa Wachuła, Anna Lewczuk, et al.
Future Oncology (London, England)|January 19, 2017
Baseline chromogranin A and its dynamics are prognostic markers in gastroenteropancreatic neuroendocrine tumorsWojciech Rogowski, Ewa Wachuła, Anna Lewczuk, et al.
Endokrynologia Polska|March 8, 2019
Capecitabine and temozolomide combination for treatment of high-grade, well-differentiated neuroendocrine tumour and poorly-differentiated neuroendocrine carcinoma - retrospective analysisWojciech Rogowski, Ewa Wachuła, Anita Gorzelak, et al.
Endokrynologia Polska|January 3, 2015
Assessment of the safety and efficiency of sunitinib malate in metastatic neuroendocrine tumours of the pancreas (NEN G1/G2) depending on the number and type of earlier therapeutic lines - initial reportEwa Wachuła, Jarosław B Ćwikła, Wojciech Rogowski, et al.
Neuroendocrinology|June 6, 2019
Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine NeoplasmsEleftherios Chatzellis, Anna Angelousi, Kosmas Daskalakis, et al.
Endokrynologia Polska|September 5, 2022
Colorectal neuroendocrine neoplasms - update of the diagnostic and therapeutic guidelines (recommended by the Polish Network of Neuroendocrine Tumours) [Nowotwory neuroendokrynne jelita grubego - uaktualnione zasady diagnostyki i leczenia (rekomendowane przez Polską Sieć Guzów Neuroendokrynych)]Teresa Starzyńska, Magdalena Londzin-Olesik, Tomasz Bednarczuk, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|January 2, 2021
Sleep disorders in oncological patientsDariusz Pysz-Waberski, Ewa Wachuła, Iwona Gisterek
Polish Archives of Internal Medicine|September 26, 2019
Emphysema affects the number and characteristics of solitary pulmonary nodules identified by chest low-dose computed tomography. A study on screenees with high-risk lung cancer recruited in Upper SilesiaEwa Wachuła, Sylwia Szabłowska-Siwik, Damian Czyżewski, et al.
Annals of Translational Medicine|May 20, 2016
Risk factors assessment and risk prediction models in lung cancer screening candidatesMariusz Adamek, Ewa Wachuła, Sylwia Szabłowska-Siwik, et al.
Endokrynologia Polska|June 28, 2014
An atypical course of pancreatic neuroendocrine tumour manifesting as cardiac metastasis - a clinical caseAgnieszka Boratyn-Nowicka, Jolanta Blicharz-Dorniak, Ewa Wachuła, et al.
Future Oncology (London, England)|May 10, 2016
Long-term efficacy of (90)Y-DOTATATE in patients with nonresectable pancreatic and small bowel neuroendocrine neoplasmsWojciech Rogowski, Ewa Wachuła, Anna Lewczuk, et al.
Future Oncology (London, England)|January 19, 2017
Baseline chromogranin A and its dynamics are prognostic markers in gastroenteropancreatic neuroendocrine tumorsWojciech Rogowski, Ewa Wachuła, Anna Lewczuk, et al.
Endokrynologia Polska|March 8, 2019
Capecitabine and temozolomide combination for treatment of high-grade, well-differentiated neuroendocrine tumour and poorly-differentiated neuroendocrine carcinoma - retrospective analysisWojciech Rogowski, Ewa Wachuła, Anita Gorzelak, et al.
Endokrynologia Polska|January 3, 2015
Assessment of the safety and efficiency of sunitinib malate in metastatic neuroendocrine tumours of the pancreas (NEN G1/G2) depending on the number and type of earlier therapeutic lines - initial reportEwa Wachuła, Jarosław B Ćwikła, Wojciech Rogowski, et al.
Neuroendocrinology|June 6, 2019
Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine NeoplasmsEleftherios Chatzellis, Anna Angelousi, Kosmas Daskalakis, et al.
Endokrynologia Polska|September 5, 2022
Colorectal neuroendocrine neoplasms - update of the diagnostic and therapeutic guidelines (recommended by the Polish Network of Neuroendocrine Tumours) [Nowotwory neuroendokrynne jelita grubego - uaktualnione zasady diagnostyki i leczenia (rekomendowane przez Polską Sieć Guzów Neuroendokrynych)]Teresa Starzyńska, Magdalena Londzin-Olesik, Tomasz Bednarczuk, et al.
Pageof 2